Form 4: Aehr Test Director Sells Shares Under 10b5-1 Plan

Aehr Test Systems director Fariba Danesh sold 9,000 shares of common stock on October 9, 2025, for approximately $223,148.

Summary

• Director Fariba Danesh of AEHR Test Systems sold a total of 9,000 shares of the company's common stock.
• The transactions occurred on October 9, 2025, and were executed under a Rule 10b5-1 pre-arranged trading plan.
• The first sale involved 2,665 shares at a price of $24.87 per share.
• The second sale involved 6,335 shares at a price of $24.755 per share.
• Following these sales, Fariba Danesh beneficially owns 16,643 shares of AEHR common stock, which includes shares subject to unvested restricted stock units.
• The Form 4 filing was signed by Chris Siu, Attorney-in-Fact, on October 10, 2025, pursuant to a Power of Attorney dated June 2, 2023.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of an insider stock sale executed under a 10b5-1 plan. While insider selling can sometimes be perceived negatively, the pre-planned nature mitigates significant negative sentiment. It provides no new information about the company's operational or financial performance.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or competitive landscape for AEHR Test Systems.

Stakeholder Impact

• Shareholders: Disclosure of a director's stock sale, which is routine under a 10b5-1 plan, but could be interpreted by some as a lack of confidence, though this is generally less likely for pre-planned sales.

Key Dates

Recommendation

The filing reports a pre-planned sale of common stock by a director under a Rule 10b5-1 plan. This is a routine disclosure and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a scheduled event rather than an opportunistic sale based on new material non-public information.

Keywords

AEHR Test Systems, AEHR, Insider Trading, Form 4, Stock Sale, Director, Fariba Danesh, 10b5-1 Plan